We are live on
!
Find out more
VFA
Values First Advisors Portfolio holdings
AUM
$192M
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$12.1M
(+7.1%)
Cap. Flow
+$761K
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
28.42%
Holding
196
New
14
Increased
88
Reduced
73
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rollins
ROL
|
+$1.72M |
| 2 |
Microchip Technology
MCHP
|
+$977K |
| 3 |
Gentex
GNTX
|
+$639K |
| 4 |
Cognex
CGNX
|
+$570K |
| 5 |
Chewy
CHWY
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$1.15M |
| 2 |
Medifast
MED
|
+$869K |
| 3 |
The Ensign Group
ENSG
|
+$771K |
| 4 |
Grand Canyon Education
LOPE
|
+$693K |
| 5 |
Amphenol
APH
|
+$551K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Healthcare | 15.61% |
| 3 | Industrials | 10.9% |
| 4 | Consumer Discretionary | 7.42% |
| 5 | Real Estate | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Frontdoor
FTDR
$5.02B
| $386K | 0.21% |
6,549
-96
| -1% | -$4.82K |
|
127
Stratasys
SSYS
$697M
| $378K | 0.21% |
32,943
+52
| +0.2% | +$527 |
|
128
Palo Alto Networks
PANW
$264B
| $376K | 0.2% |
1,839
+372
| +25% | +$69.1K |
|
129
Iridium Communications
IRDM
$4.85B
| $374K | 0.2% |
12,380
+89
| +0.7% | +$2.31K |
|
130
Fair Isaac
FICO
$28.7B
| $373K | 0.2% |
204
-1
| -0.5% | -$1.88K |
|
131
Vanguard Information Technology ETF
VGT
$139B
| $371K | 0.2% |
4,480
| – | – |
|
132
America's Car Mart
CRMT
$25.3M
| $367K | 0.2% |
6,550
+10
| +0.2% | +$495 |
|
133
Innodata
INOD
$1.83B
| $366K | 0.2% |
+7,139
| New | +$282K |
|
134
Central Garden & Pet Co
CENT
$2.74B
| $358K | 0.19% |
10,163
+24
| +0.2% | +$848 |
|
135
Arthur J. Gallagher & Co
AJG
$63.7B
| $352K | 0.19% |
1,100
-123
| -10% | -$40.5K |
|
136
Mistras Group
MG
$492M
| $348K | 0.19% |
43,407
+85
| +0.2% | +$715 |
|
137
Timothy Plan US Large/Mid Cap Core ETF
TPLC
$307M
| $346K | 0.19% |
7,714
+26
| +0.3% | +$1.11K |
|
138
AMERISAFE
AMSF
$569M
| $344K | 0.19% |
7,867
+2,503
| +47% | +$118K |
|
|
ESUM
139
Eventide US Market ETF
ESUM
$180M
| $338K | 0.18% |
13,016
+3,233
| +33% | +$78.3K |
|
140
Remitly
RELY
$4.74B
| $337K | 0.18% |
17,941
+2,284
| +15% | +$47.5K |
|
141
Boston Scientific
BSX
$65.8B
| $332K | 0.18% |
3,090
-18
| -0.6% | -$1.82K |
|
142
International Paper
IP
$22.3B
| $323K | 0.18% |
+6,890
| New | +$326K |
|
143
Americold
COLD
$4.09B
| $322K | 0.18% |
19,349
-160
| -0.8% | -$2.9K |
|
144
CrowdStrike
CRWD
$187B
| $317K | 0.17% |
2,488
-28
| -1% | -$3.04K |
|
145
Olin
OLN
$2.64B
| $310K | 0.17% |
15,452
+185
| +1% | +$3.84K |
|
146
Huntington Bancshares
HBAN
$35.1B
| $305K | 0.17% |
18,175
-9,361
| -34% | -$141K |
|
147
Berkshire Hathaway Class B
BRK.B
$1.07T
| $302K | 0.16% |
621
| – | – |
|
148
SAP
SAP
$187B
| $296K | 0.16% |
+973
| New | +$279K |
|
149
Eli Lilly
LLY
$1.07T
| $283K | 0.15% |
363
-118
| -25% | -$91.7K |
|
150
Public Service Enterprise Group
PEG
$39.8B
| $268K | 0.15% |
3,179
-112
| -3% | -$9.03K |
|
Similar funds
KWM
SCGDR
KC
CVSC
CA
WIA
AGA
LFIA
Values First Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Values First Advisors held 196 positions worth $184M, up 7.1% from $171M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Values First Advisors's Q2 2025 filing shows 14 new, 88 increased, 73 reduced and 15 closed positions. Its largest new stake was Rollins: 30,743 shares worth $1.73M. The largest sale was Alnylam Pharmaceuticals, an estimated $1.15M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
- Values First Advisors's largest Q2 2025 buy was Rollins: 30,743 shares worth $1.73M.
- Values First Advisors added most to Microchip Technology in Q2 2025, an estimated $977K increase.
- Values First Advisors's biggest Q2 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.15M.
- Values First Advisors fully exited Medifast in Q2 2025, selling an estimated $869K.
- Values First Advisors's ten largest holdings make up 28% of its $184M portfolio in Q2 2025.
- Values First Advisors opened 14 new positions and closed 15 in Q2 2025.
- Values First Advisors's portfolio value rose 7.1% quarter-over-quarter to $184M.
Based on Values First Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.